Brazil Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 109 Pages I Mordor Intelligence
Brazil Diabetes Devices Market Analysis
The Brazil diabetes devices market is valued at USD 1.12 billion in 2025 and is forecast to reach USD 1.47 billion by 2030, reflecting a 5.62% CAGR over the period. Growth is propelled by a rising diabetic population of 16.8 million people in 2024, broader national screening programs, and rapid adoption of digital health tools that streamline patient engagement and data sharing. Device manufacturers are localizing production to comply with domestic regulation while meeting increasing demand for innovative glucose monitors and insulin delivery systems. At the same time, government subsidy schemes are expanding reimbursement, improving affordability in lower-income regions, and boosting volume sales. Competitive pressure is sharpening as multinationals and domestic firms pursue hybrid solutions that blend affordability with advanced functionality, a combination well suited to varied Brazilian income levels and care settings.
Brazil Diabetes Devices Market Trends and Insights
Growing Prevalence of Obesity and Diabetes
Brazil's adult obesity rate is projected to reach 48% by 2044, climbing from 28.2% in 2022 . This trend is closely tied to a modeled surge in type 2 diabetes prevalence from 9.2% to 27.0% by 2036. Rising disease burden is translating into stronger demand for sophisticated monitoring devices, especially CGM systems that integrate with weight-management apps and offer continuous insights. Younger adults now face earlier diagnoses, creating a consumer segment that values mobility, connectivity, and preventative analytics. Manufacturers are responding with integrated platforms that link glucose tracking to lifestyle coaching, a product-mix shift that boosts average device value. The driver's influence is amplified in more industrialized Southeast and South regions where obesity rates and disposable incomes are highest.
Rising Geriatric Population
Brazil's population aged 65 plus is forecast to double by 2050, with current studies showing diabetes prevalence of 18.5% in seniors versus 6.4% nationally. This demographic demands devices with larger displays, simplified interfaces, and caregiver-friendly data sharing. Older users often prefer hybrid monitoring-combining manual logging with digital dashboards-prompting suppliers to redesign CGM receivers and SMBG meters for clarity and tactile feedback. Extended life expectancy means longer treatment horizons, thus enlarging cumulative device consumption. Urban centers see the greatest impact because specialist clinics and telehealth infrastructure simplify elderly onboarding. Over the long term, device makers that cater to ergonomic and usability needs will consolidate share among this expanding cohort.
Low Endocrinologist Density
Specialist scarcity limits advanced device adoption in interior municipalities; many complex CGM or pump systems require prescription and follow-up from endocrinologists. Tele-consult pilots such as UBS+Digital achieved an 85% resolution rate across 6,312 sessions, indicating partial relief Nonetheless, inconsistent broadband and digital literacy temper results, leaving uptake uneven outside large cities. Manufacturers are partnering with nursing networks and primary-care physicians to widen training reach, yet rollout speed remains tied to professional capacity.
Other drivers and restraints analyzed in the detailed report include:
Integration of Digital Health Solutions / National Diabetes Screening Expansion / Stringent Regulations / High Costs /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Self-monitoring blood glucose still dominated with 62% revenue share of the Brazil diabetes devices market in 2024. The segment's consumable test strips generate steady sales, while glucometers and lancets have slower replacement cycles. CGM systems, however, are projected to register a 6.5% CAGR through 2030, reshaping the monitoring mix. Brazil diabetes devices market size for CGM is forecast to expand alongside demand for round-the-clock insights that connect to physician dashboards, a feature valued by both public and private insurers for its potential to lower complication-related costs.
SMBG remains indispensable where Farmacia Popular covers strips and meters, driving high penetration across income brackets. Suppliers now embed Bluetooth in affordable meters so that data integrate with mobile apps, narrowing functionality gaps with CGM. As a result, hybrid products are emerging: fingerstick meters that prompt automated coaching via smartphones, offering an accessible entry point for patients phased into continuous sensing over time. This staged upgrade path supports gradual revenue lift while keeping initial out-of-pocket expense modest.
Disposable insulin pens captured 45% share of the Brazil diabetes devices market in 2024 thanks to their dosing accuracy and broad reimbursement. Insulin pumps, although a smaller base, are forecast to grow 5.9% CAGR by 2030 as closed-loop algorithms and simplified user interfaces improve patient acceptance. Brazil diabetes devices market share for pumps is bolstered by partnerships that integrate Abbott sensors with Medtronic delivery hardware, creating near-automated glycemic control.
Reusable pens using insulin cartridges appeal to environmentally conscious users and institutions seeking waste reduction. Syringes and jet injectors, once predominant, now serve cost-constrained settings. Across categories, convergence is under way: manufacturers bundle pen devices with cloud apps that record injections and combine the logs with glucose data, supporting physician titration decisions and adherence reporting.
The Brazil Diabetes Devices Market Report Segments the Industry Into (Management Devices and Monitoring Devices), End User (Hospitals & Clinics, Home-Care Settings, and Retail Pharmacies & Diabetes Centers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce / Online Pharmacies), and Region. The Market Sizes and Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Abbott Laboratories / Roche / Lifescan / Medtronic / Novo Nordisk / Dexcom / Terumo / Eli Lilly and Company / Sanofi / Arkray / Beckton Dickinson / Ascensia / Ypsomed / Insulet / Tandem Diabetes Care / Nipro Diagnostics / OMRON / B. Braun /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of Obesity & Associated Diabetes
4.2.2 Rising Geriatric Population
4.2.3 Integration of Digital Health Solutions
4.2.4 Rapid CGM adoption after ANVISA reimbursement inclusion (SUS & private)
4.2.5 Surge in Brazilian e-pharmacy platforms enabling D-to-C device sales
4.2.6 National Diabetes Screening Program Expansions Driving Device Uptake
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Import tariffs (14-16 %) on CGM transmitters
4.3.3 Low Endocrinologists Density
4.3.4 High Costs
4.4 Value / Supply-Chain Analysis
4.5 Regulatory & Technological Outlook
4.6 Porter's Five Forces Analysis
4.6.1 Bargaining Power of Suppliers
4.6.2 Bargaining Power of Buyers
4.6.3 Threat of New Entrants
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Device Category
5.1.1 Monitoring Devices
5.1.1.1 Self-Monitoring Blood Glucose (SMBG) Devices
5.1.1.1.1 Glucometers
5.1.1.1.2 Test Strips
5.1.1.1.3 Lancets
5.1.1.2 Continuous Glucose Monitoring (CGM) Devices
5.1.1.2.1 Sensors
5.1.1.2.2 Durables (Receivers & Transmitters)
5.1.2 Management Devices
5.1.2.1 Insulin Delivery Devices
5.1.2.1.1 Insulin Pump Devices
5.1.2.1.2 Insulin Disposable Pens
5.1.2.1.3 Insulin Cartridges in Re-usable Pens
5.1.2.1.4 Insulin Syringes & Jet Injectors
5.2 By End User
5.2.1 Hospitals & Clinics
5.2.2 Home-Care Settings
5.2.3 Retail Pharmacies & Diabetes Centers
5.3 By Distribution Channel
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 E-commerce / Online Pharmacies
5.4 By Region (Brazil)
5.4.1 Southeast
5.4.2 South
5.4.3 Northeast
5.4.4 North
5.4.5 Central-West
6 Market Indicators
6.1 Type-1 Diabetes Population
6.2 Type-2 Diabetes Population
7 Competitive Landscape
7.1 Market Concentration
7.2 Strategic Moves
7.3 Market Share Analysis
7.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
7.4.1 Abbott Diabetes Care
7.4.2 Roche Diabetes Care
7.4.3 LifeScan
7.4.4 Medtronic
7.4.5 Novo Nordisk A/S
7.4.6 Dexcom
7.4.7 Terumo
7.4.8 Eli Lilly
7.4.9 Sanofi
7.4.10 Arkray
7.4.11 Becton Dickinson
7.4.12 Ascensia Diabetes Care
7.4.13 Ypsomed
7.4.14 Insulet Corporation
7.4.15 Tandem Diabetes Care
7.4.16 Nipro Diagnostics
7.4.17 Omron Healthcare
7.4.18 B. Braun Melsungen
8 Market Opportunities & Future Outlook
8.1 White-Space & Unmet-Need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.